Patents by Inventor Kevin Cannon

Kevin Cannon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200254163
    Abstract: A system and method used to deliver a percutaneous ventricular assist device (pVAD) or other cardiac therapeutic device to a site within the heart, such as a site at the aortic valve. A flexible device is percutaneously introduced into a vasculature of a patient and positioned to run from a femoral vein, through the heart via a transseptal puncture, and to a femoral artery. The venous-side end of the flexible device is withdrawn out the venous vasculature superior to the heart, and a pVAD is secured to the flexible device. The pVAD is pushed in a distal direction while the arterial-side end of the flexible device is pulled in the proximal direction to advance the pVAD to the target site. A left ventricle redirector aids in orienting the pVAD and preventing migration of the flexible member towards delicate structures of the heart during advancement of the pVAD.
    Type: Application
    Filed: September 22, 2019
    Publication date: August 13, 2020
    Inventors: Richard S Stack, William L Athas, Kevin Johnson, Emer M Feerick, Matthew Moran, Damian Muldoon, Liam Ruddy, William Cannon, Rory O'Brien
  • Publication number: 20200254166
    Abstract: A system and method used to deliver a percutaneous ventricular assist device (pVAD) or other cardiac therapeutic device to a site within the heart, such as a site at the aortic valve. A flexible device is percutaneously introduced into a vasculature of a patient and positioned to run from a femoral vein, through the heart via a transseptal puncture, and to a femoral artery. The venous-side end of the flexible device is withdrawn out the venous vasculature superior to the heart, and a pVAD is secured to the flexible device. The pVAD is pushed in a distal direction while the arterial-side end of the flexible device is pulled in the proximal direction to advance the pVAD to the target site. A left ventricle redirector aids in orienting the pVAD and preventing migration of the flexible member towards delicate structures of the heart during advancement of the pVAD.
    Type: Application
    Filed: September 22, 2019
    Publication date: August 13, 2020
    Inventors: Richard S. Stack, William L. Athas, Kevin Johnson, Emer M. Feerick, Matthew Moran, Damian Muldoon, Liam Ruddy, William Cannon, Rory O'Brien
  • Publication number: 20190226903
    Abstract: Methods and apparatus to measure mass in low gravity environments are disclosed. A disclosed example low-gravity mass-measuring apparatus includes a coupler to couple a coupling portion to an object, the coupling portion including a first inertial measurement unit (IMU), a force device to provide a force to cause a movement of a dock relative to the coupling portion, where the dock is releasably couplable to the coupling portion and includes a second IMU, and a processor to calculate a mass of the object based on movement data from the first and second IMUs and the force.
    Type: Application
    Filed: January 19, 2018
    Publication date: July 25, 2019
    Inventor: Kevin Cannon
  • Publication number: 20160289062
    Abstract: A packaged electronic component comprising at least one movable part, comprising lower and upper layers, each formed with a depression in an inwards-facing side of the component, the depressions forming a cavity within the component, a MEMs component rigidly joined at least one proximal location to the lower and upper layers, wherein the MEMs component extends from the at least one proximal location into the cavity such that a distal region of the MEMs component can move within the cavity.
    Type: Application
    Filed: March 31, 2015
    Publication date: October 6, 2016
    Inventor: Kevin CANNON
  • Publication number: 20160141232
    Abstract: An integrated circuit package comprising a semiconductor die, a lead frame lying in a first plane, at least one conductive pillar structure extending outwardly from the first plane, wherein the lead frame and the at least one conductive pillar structure are formed of sintered conductive material, encapsulation material which encapsulates the semiconductor die, the lead frame and the at least one conductive pillar structure, a conductive layer on an upper face of the package, the conductive layer conductively connecting to the at least one conductive pillar. Methods of manufacturing are also disclosed.
    Type: Application
    Filed: November 19, 2014
    Publication date: May 19, 2016
    Inventor: Kevin Cannon
  • Patent number: 6124380
    Abstract: The invention comprises a curable composition comprising: (i) a blocked reactive component wherein the blocked reactive component is a blocked isocyanate or a blocked isothiocyanate; (ii) a functional compound reactive with the blocked reactive component, the functional compound containing reactive hydrogen; (iii) a catalyst for promoting the reaction of the reactive component with the blocked functional compound, wherein said catalyst is based on the reaction product of manganese, cobalt, nickel, copper, zinc, germanium, antimony, or bismuth, or the oxides thereof with a mercaptan, or an organic acid, wherein said organic acid is hexanoic, oxalic, adipic, lactic, tartaric, salicylic, thioglycolic, succinic, or mercapto succinic acid, or the reaction product of copper or germanium, or the oxides thereof with a lower aliphatic acid.
    Type: Grant
    Filed: March 12, 1999
    Date of Patent: September 26, 2000
    Assignee: Elf Atochem North America, Inc.
    Inventors: Emily C. Bossert, Kevin Cannon, William D. Honnick, Wayne Ranbom
  • Patent number: 6042893
    Abstract: The invention comprises a curable composition comprising: (i) a blocked reactive component wherein the blocked reactive component is a blocked isocyanate or a blocked isothiocyanate; (ii) a functional compound reactive with the blocked reactive component, the functional compound containing reactive hydrogen; (iii) a catalyst for promoting the reaction of the reactive component with the blocked functional compound, wherein said catalyst is based on the reaction product of manganese, cobalt, nickel, copper, zinc, germanium, antimony, or bismuth, or the oxides thereof with a mercaptan, or an organic acid, wherein said organic acid is hexanoic, oxalic, adipic, lactic, tartaric, salicylic, thioglycolic, succinic, or mercapto succinic acid, or the reaction product of copper or germanium, or the oxides thereof with a lower aliphatic acid.
    Type: Grant
    Filed: March 12, 1999
    Date of Patent: March 28, 2000
    Assignee: Elf Atochem North America Inc.
    Inventors: Emily C. Bossert, Kevin Cannon, William D. Honnick, Wayne Ranbom
  • Patent number: 6028128
    Abstract: The invention comprises a curable composition comprising: (i) a blocked reactive component wherein the blocked reactive component is a blocked isocyanate or a blocked isothiocyanate; (ii) a functional compound reactive with the blocked reactive component, the functional compound containing reactive hydrogen; (iii) a catalyst for promoting the reaction of the reactive component with the blocked functional compound, wherein said catalyst is based on the reaction product of manganese, cobalt, nickel, copper, zinc, germanium, antimony, or bismuth, or the oxides thereof with a mercaptan, or an organic acid, wherein said organic acid is hexanoic, oxalic, adipic, lactic, tartaric, salicylic, thioglycolic, succinic, or mercapto succinic acid, or the reaction product of copper or germanium, or the oxides thereof with a lower aliphatic acid.
    Type: Grant
    Filed: October 19, 1998
    Date of Patent: February 22, 2000
    Assignee: ELF Atochem North America, Inc.
    Inventors: Emily C. Bossert, Kevin Cannon, William D. Honnick, Wayne Ranbom
  • Patent number: 6001900
    Abstract: The invention comprises a curable composition comprising: (i) a blocked reactive component wherein the blocked reactive component is a blocked isocyanate or a blocked isothiocyanate; (ii) a functional compound reactive with the blocked reactive component, the functional compound containing reactive hydrogen; (iii) a catalyst for promoting the reaction of the reactive component with the blocked functional compound, wherein said catalyst is based on the reaction product of manganese, cobalt, nickel, copper, zinc, germanium, antimony, or bismuth, or the oxides thereof with a mercaptan, or an organic acid, wherein said organic acid is hexanoic, oxalic, adipic, lactic, tartaric, salicylic, thioglycolic, succinic, or mercapto succinic acid, or the reaction product of copper or germanium, or the oxides thereof with a lower aliphatic acid.
    Type: Grant
    Filed: June 13, 1997
    Date of Patent: December 14, 1999
    Assignee: Elf Atochem North America, Inc.
    Inventors: Emily C. Bossert, Kevin Cannon, William D. Honnick, Wayne Ranbom
  • Patent number: 5910373
    Abstract: The invention comprises a curable composition comprising: (i) a blocked reactive component wherein the blocked reactive component is a blocked isocyanate or a blocked isothiocyanate; (ii) a functional compound reactive with the blocked reactive component, the functional compound containing reactive hydrogen.; (iii) a catalyst for promoting the reaction of the reactive component with the blocked functional compound, wherein said catalyst is based on the reaction product of manganese, cobalt., nickel, copper, zinc, germanium, antimony, or bismuth, or the oxides thereof with a mercaptan, or an organic acid, wherein said organic acid is hexanoic, oxalic, adipic, lactic, tartaric, salicylic, thioglycolic, succinic, or mercapto succinic acid, or the reaction product of copper or germanium, or the oxides thereof with a lower aliphatic acid.
    Type: Grant
    Filed: June 13, 1997
    Date of Patent: June 8, 1999
    Assignee: Elf Atochem North America, Inc.
    Inventors: Emily C. Bossert, Kevin Cannon, William D. Honnick, Wayne Ranbom
  • Patent number: 5859165
    Abstract: The invention comprises a curable composition comprising:(i) a blocked reactive component wherein the blocked reactive component is a blocked isocyanate or a blocked isothiocyanate;(ii) a functional compound reactive with the blocked reactive component, the functional compound containing reactive hydrogen;(iii) a catalyst for promoting the reaction of the reactive component with the blocked functional compound, wherein said catalyst is based on the reaction product of manganese, cobalt, nickel, copper, zinc, germanium, antimony, or bismuth, or the oxides thereof with a mercaptan, or an organic acid, wherein said organic acid is hexanoic, oxalic, adipic, lactic, tartaric, salicylic, thioglycolic, succinic, or mercapto succinic acid, or the reaction product of copper or germanium, or the oxides thereof with a lower aliphatic acid.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: January 12, 1999
    Assignee: Elf Atochem North America, Inc.
    Inventors: Emily C. Bossert, Kevin Cannon, William D. Honnick, Wayne Ranbom